Search Results - "VOGEL, Kristen J"

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing by Susswein, Lisa R., Marshall, Megan L., Nusbaum, Rachel, Vogel Postula, Kristen J., Weissman, Scott M., Yackowski, Lauren, Vaccari, Erica M., Bissonnette, Jeffrey, Booker, Jessica K., Cremona, M. Laura, Gibellini, Federica, Murphy, Patricia D., Pineda-Alvarez, Daniel E., Pollevick, Guido D., Xu, Zhixiong, Richard, Gabi, Bale, Sherri, Klein, Rachel T., Hruska, Kathleen S., Chung, Wendy K.

“…Germ-line testing for panels of cancer genes using next-generation sequencing is becoming more common in clinical care. We report our experience as a clinical…”
Get full text

The Evolution of Cancer Risk Assessment in the Era of Next Generation Sequencing by Fecteau, Heather, Vogel, Kristen J., Hanson, Kristen, Morrill-Cornelius, Shannon

“…Cancer genetics professionals face a new opportunity and challenge in adapting to the availability of cancer genetic testing panels, now available as a result…”
Get full text

Cancer Genetic Counseling and Testing in an Era of Rapid Change by Hooker, Gillian W., Clemens, Keelia Rhoads, Quillin, John, Vogel Postula, Kristen J., Summerour, Pia, Nagy, Rebecca, Buchanan, Adam H.

“…The impacts of the Association for Molecular Pathology vs. Myriad Supreme Court decision regarding patenting DNA segments and multi-gene testing on cancer…”
Get full text

Accuracy of Perceived Breast Cancer Risk in Black and White Women with an Elevated Risk by Young, Jessica M L, Postula, Kristen J Vogel, Duquette, Debra, Gutierrez-Kapheim, Melissa, Pan, Vivian, Katapodi, Maria C

“…Perceived breast cancer risk predicts screening behaviors. However, perceived risk is often inaccurate, notably in Black women, who often underestimate their…”
Get full text

Urologists' Current Practices in Screening and Treating Men with a Family History of Prostate Cancer by Rudichuk, Lauren, MS, CGC, Vogel, Kristen J., MS, CGC, Wang, Chi-hsiung, PhD, Helfand, Brian T., MD, PhD, Selkirk, Christina G., MS, CCRP

“…Abstract Objective To assess urologists' knowledge and utilization of family history in order to determine prostate cancer (PC) screening and treatment…”
Get full text

Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study by ANDERSON, Michelle A, ZOLOTAREVSKY, Eugene, SASSON, Aaron R, GRIZZLE, William E, KETCHAM, Marsha A, LEE, Shih-Yuan, NORMOLLE, Daniel, PLONKA, Caitlyn M, MERTENS, Amy N, TRIPON, Renee C, BRAND, Randall E, COOPER, Kristine L, SHERMAN, Simon, SHATS, Oleg, WHITCOMB, David C, LYNCH, Henry T, GHIORZO, Paola, RUBINSTEIN, Wendy S, VOGEL, Kristen J

“…The objective of this study was to examine the association between tobacco and alcohol dose and type and the age of onset of pancreatic adenocarcinoma…”
Get full text

Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment by Baumgart, Leigh A., Postula, Kristen J. Vogel, Knaus, William A.

“…Personal and family health histories remain important independent risk factors for cancer; however they are currently not being well collected or used…”
Get full text

Utilization of breast cancer risk prediction models by cancer genetic counselors in clinical practice predominantly in the United States by Park, Min Seon, Weissman, Scott M., Postula, Kristen J. Vogel, Williams, Carmen S., Mauer, Caitlin B., O’Neill, Suzanne M

“…Risk assessment in cancer genetic counseling is essential in identifying individuals at high risk for developing breast cancer to recommend appropriate…”
Get full text

BRCA1 and BRCA2 Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model by VOGEL, Krtsten J, ATCHLEY, Deann P, ERLICHMAN, Julie, BROGLIO, Kristine R, READY, Kaylene J, VALERO, Vicente, AMOS, Christopher I, HORTOBAGYI, Gabriel N, LU, Karen H, ARUN, Banu

“…The BRCAPRO model, used to predict a family's likelihood of carrying a BRCA1 or BRCA2 mutation, was designed using mutation frequencies of white and Ashkenazi…”
Get full text

FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices by Buchtel, Kathryn M., Vogel Postula, Kristen J., Weiss, Shelly, Williams, Carmen, Pineda, Mario, Weissman, Scott M.

“…In December 2014, the FDA approved olaparib, a poly(ADP-ribose) polymerase inhibitor (PARPi) for ovarian cancer patients who have failed three or more lines of…”
Get full text

Evaluation of laboratory perspectives on hereditary cancer panels by Stoll, Jessica, Weissman, Scott M., Hook, Nicole, Selkirk, Christina, Johnson, Amy Knight, Newlin, Anna, Vogel Postula, Kristen J.

“…Genetic counseling and testing for hereditary cancer susceptibility is a rapidly evolving field and partly a result of next-generation sequencing (NGS)…”
Get full text

Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer by Thompson, Amanda Bartenbaker, Sutcliffe, Erin G., Arvai, Kevin, Roberts, Maegan E., Susswein, Lisa R., Marshall, Megan L., Torene, Rebecca, Postula, Kristen J. Vogel, Hruska, Kathleen S., Bai, Shaochun

“…We aimed to determine whether monoallelic MUTYH pathogenic and likely pathogenic variants (PVs) are associated with colorectal, breast, and endometrial cancer…”
Get full text

Family Physicians’ Awareness and Knowledge of the Genetic Information Non-Discrimination Act (GINA) by Laedtke, Amanda L., O’Neill, Suzanne M., Rubinstein, Wendy S., Vogel, Kristen J.

“…Historically, physicians have expressed concern about their patients’ risk of genetic discrimination, which has acted as a barrier to uptake of genetic…”
Get full text

Learning to Say No by Vogel, Kristen J.

“…The author reflects on issues of being overworked and professional burnout. Part of a special journal issue focused on 'defining moments' in genetic counselor…”
Get full text

Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice by Selkirk, Christina G., Vogel, Kristen J., Newlin, Anna C., Weissman, Scott M., Weiss, Shelly M., Wang, Chi-Hsiung, Hulick, Peter J.

“…Next-generation sequencing genetic testing panels for cancer susceptibility (cancer panels) have recently become clinically available. At present, clinical…”
Get full text

Tu1874 Earlier Age of Presentation of Pancreatic Adenocarcinoma in Individuals With Chronic Pancreatitis by Mohanty, Arpan, Shah, Nilesh H, Anderson, Michelle A, Sasson, Aaron R, Vogel, Kristen J, Sherman, Simon, Whitcomb, David C, Brand, Randall

Get full text

10 rare tumors that warrant a genetics referral by Banks, Kimberly C., Moline, Jessica J., Marvin, Monica L., Newlin, Anna C., Vogel, Kristen J.

“…The number of described cancer susceptibility syndromes continues to grow, as does our knowledge on how to manage these syndromes with the aim of early…”
Get full text

Genetic counselors’ perspectives on population‐based screening for BRCA‐related hereditary breast and ovarian cancer and Lynch syndrome by De Simone, Lenika M., Arjunan, Aishwarya, Vogel Postula, Kristen J., Maga, Tara, Bucheit, Leslie A.

“…Early identification of those with BRCA‐related Hereditary Breast and Ovarian Cancer Syndrome (HBOC) and Lynch syndrome has the potential for early cancer…”
Get full text

Using a Family History Intervention to Improve Cancer Risk Perception in a Black Community by Murthy, Vinaya S., Garza, Mary A., Almario, Donna A., Vogel, Kristen J., Grubs, Robin E., Gettig, Elizabeth A., Wilson, John W., Thomas, Stephen B.

“…Few studies examine the use of family history to influence risk perceptions in the African American population. This study examined the influence of a family…”
Get full text

Accuracy of the BRCAPRO model among women with bilateral breast cancer by Ready, Kaylene J., Vogel, Kristen J., Atchley, Deann P., Broglio, Kristine R., Solomon, Kimberly K., Amos, Christopher, Lu, Karen H., Hortobagyi, Gabriel N., Arun, Banu

“…BACKGROUND: The likelihood of identifying a BRCA mutation was often calculated using the BRCAPRO model. A previous study suggested that this model may…”
Get full text